Virbac SA
VIRP
Company Profile
Business description
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by Asia and Latin America.
Contact
2065m LID
1 ere avenue
Carros06516
FRAE: finances@virbac.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
5,620
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,989.90 | 30.20 | 0.38% |
| CAC 40 | 7,273.12 | 168.32 | 2.37% |
| DAX 40 | 20,954.83 | 580.73 | 2.85% |
| Dow JONES (US) | 40,524.79 | 312.08 | 0.78% |
| FTSE 100 | 8,134.34 | 170.16 | 2.14% |
| HKSE | 21,393.20 | 24.20 | -0.11% |
| NASDAQ | 16,831.48 | 107.03 | 0.64% |
| Nikkei 225 | 34,285.02 | 302.66 | 0.89% |
| NZX 50 Index | 12,073.39 | 34.15 | -0.28% |
| S&P 500 | 5,405.97 | 42.61 | 0.79% |
| S&P/ASX 200 | 7,781.10 | 32.50 | 0.42% |
| SSE Composite Index | 3,253.25 | 9.56 | -0.29% |